Literature DB >> 16472125

High glucose-mediated imbalance of nitric oxide synthase and dimethylarginine dimethylaminohydrolase expression in endothelial cells.

Valeria Sorrenti1, Francesco Mazza, Agata Campisi, Luca Vanella, Giovanni Li Volti, Claudia Di Giacomo.   

Abstract

The mechanisms involved in endothelial dysfunction are multifactorial. A correlation between oxidative stress and derangements of nitric oxide synthase (NOS) pathways in altered endothelial homeostasis has been most studied and demonstrated in different pathophysiological conditions. NOS activities are regulated by endogenous inhibitors such as asymmetric dimethyl-L-arginine (ADMA) that is metabolized by dimethylarginine dimethylaminohydrolase (DDAH). Since recent data demonstrated that some endothelial dysfunction may be related to reduced expression and/or activity of DDAH, the aim of the present research was to investigate the expression of DDAH-2 and NOS isoforms in high glucose-mediated oxidative stress. Endothelial cells were incubated with normal (7 mM) and high concentrations (33 mM) of D-glucose for 5 days; mannose (26 mM) plus D-glucose (7 mM) was used as osmotic control. Data obtained in the present study show that the exposure for 5 days to high glucose increases oxidative stress, reduces DDAH-2 and eNOS expression and increases iNOS expression. These results indicate that DDAH-2 and iNOS/eNOS dysregulation may play a key role in high glucose-mediated oxidative stress, suggesting that selective modulation of DDAH isoforms may result in selective inhibition/activation of NOS isoforms, thereby providing a novel strategy of approach in vascular complications of several pathologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472125     DOI: 10.2174/156720206775541778

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  8 in total

1.  Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advanced glycation end products.

Authors:  Ying-Ling Lai; Sae Aoyama; Ryoji Nagai; Noriyuki Miyoshi; Hiroshi Ohshima
Journal:  J Clin Biochem Nutr       Date:  2010-02-27       Impact factor: 3.114

2.  Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

Authors:  Björn Ellger; Lies Langouche; Milan Richir; Yves Debaveye; Ilse Vanhorebeek; Tom Teerlink; Paul A Van Leeuwen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 17.440

3.  Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.

Authors:  Sara Franceschelli; Alessio Ferrone; Mirko Pesce; Graziano Riccioni; Lorenza Speranza
Journal:  Int J Mol Sci       Date:  2013-12-16       Impact factor: 5.923

Review 4.  Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Toxins (Basel)       Date:  2017-03-06       Impact factor: 4.546

5.  Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

Authors:  Angelika Chachaj; Jerzy Wiśniewski; Justyna Rybka; Aleksandra Butrym; Monika Biedroń; Małgorzata Krzystek-Korpacka; Mariusz Grzegorz Fleszar; Maciej Karczewski; Tomasz Wróbel; Grzegorz Mazur; Andrzej Gamian; Andrzej Szuba
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

6.  Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma.

Authors:  Corina Daniela Ene; Mircea Nicolae Penescu; Simona Roxana Georgescu; Mircea Tampa; Ilinca Nicolae
Journal:  Metabolites       Date:  2020-12-27

7.  Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease.

Authors:  Heidi Borgeraas; Elin Strand; Eva Ringdal Pedersen; Jutta Dierkes; Per Magne Ueland; Reinhard Seifert; Eirik Rebnord Wilberg; Pavol Bohov; Rolf K Berge; Dennis W T Nilsen; Ottar Nygård
Journal:  Cardiol Res Pract       Date:  2012-12-31       Impact factor: 1.866

8.  Poor glycemic control is related to increased nitric oxide activity within the renal circulation of patients with type 2 diabetes.

Authors:  Markus P Schneider; Christian Ott; Stephanie Schmidt; Iris Kistner; Stefanie Friedrich; Roland E Schmieder
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.